サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1756435

臨床試験用セントラルラボサービスの世界市場：サービス別・フェーズ別・適応症別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Clinical Trial Central Laboratory Services Market, By Service, By Phase, By Indication, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 395 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
臨床試験用セントラルラボサービスの世界市場：サービス別・フェーズ別・適応症別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2025年05月23日
発行: AnalystView Market Insights
ページ情報: 英文 395 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

臨床試験用セントラルラボサービスの市場規模は2024年に41億2,312万米ドルとなり、2024年から2032年にかけてCAGR 9.6%で拡大

臨床試験用セントラルラボサービスの市場力学

効率的な臨床試験管理への需要の高まり

臨床試験の複雑化と規模の拡大が、臨床試験用セントラルラボサービスの需要を促進しています。一元化されたラボは、複数の臨床試験の実施施設で標準化された検査と一貫したデータ品質を提供し、ばらつきやエラーを低減します。この効率化により、意思決定や薬事承認プロセスが加速されます。さらに、医薬品の革新と個別化医療に後押しされた世界の臨床試験の増加により、信頼性の高い集中型検査施設が必要とされています。データ管理機能の強化とデジタルプラットフォームとの統合は、試験の正確性とコンプライアンスをさらにサポートします。全体として、これらの要因がセントラルラボサービスの採用拡大に寄与し、市場の成長を促進しています。

臨床試験用セントラルラボサービス市場：主な考察

当社のリサーチアナリストによると、世界の臨床試験用セントラルラボサービス市場は、2024年から2032年にかけて約9.6%のCAGRで開発される見込みです。

サービス別では、2023年にバイオマーカー検査サービスが市場を独占しています。

適応症別では、2023年に最も収益を上げたのは腫瘍領域でした。

地域別では、2023年に北米が最も収益を上げた地域でした。

臨床試験用セントラルラボサービス市場：セグメンテーション分析

世界の臨床試験用セントラルラボサービス市場は5つのカテゴリーに分類されます。サービス、フェーズ、エンドユース、適応症、地域です。

サービス別では、臨床試験用セントラルラボサービス市場はいくつかの主要カテゴリーに区分されます。バイオマーカー検査サービス、微生物学サービス、解剖病理学/組織学、薬物動態学/薬力学（PK/PD）、ゲノム・分子検査、検体採取・処理、ロジスティクス・検体管理、データ管理・報告、その他です。各サービスは、専門的な検査、検体処理、データ分析を通じて臨床試験をサポートする上で重要な役割を果たしています。中でもバイオマーカー検査サービスは、個別化医療や標的治療において極めて重要であるため、市場を独占しています。バイオマーカーは、疾患の進行、治療効果、安全性の評価に役立つため、医薬品開発には不可欠です。精密医療への注目の高まりとバイオマーカー探索の進歩が、これらのサービスへの高い需要を後押ししており、バイオマーカー検査は臨床試験センターにおける主要セグメントとして位置づけられています。

適応症別では、臨床試験用セントラルラボサービス市場は、腫瘍、心臓病、神経症、感染症、免疫・自己免疫疾患、その他に区分されます。これらのセグメントは、臨床試験中に専門的な検査サポートを必要とする多様な治療領域を表しています。なかでも腫瘍領域は、世界のがん罹患率の高さ、標的がん治療や免疫療法の急速な開発により、市場開拓において優位な地位を占めています。複雑な腫瘍学臨床試験では、広範なバイオマーカー検査、ゲノム解析、頻繁なモニタリングが要求されるため、セントラルラボサービスへの依存度が高いです。さらに、腫瘍研究および個別化医療への投資の増加は、この分野の成長をさらに促進し、臨床試験用セントラルラボサービス市場における主要な適応分野となっています。

臨床試験用セントラルラボサービス市場：地域別分析

地域的には、臨床試験用セントラルラボサービス市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米は、先進的な医療インフラ、製薬会社やバイオテクノロジー企業の強い存在感、臨床試験の多さによって、臨床試験用セントラルラボサービス市場の支配的な地域となっています。特に米国は、強固な規制の枠組み、多額の研究資金、革新的な技術の採用によりリードしています。同地域では精密医療が重視され、複雑なバイオマーカーやゲノム検査に対する需要が高まっていることが、市場の成長をさらに後押ししています。さらに、学術機関と業界関係者の連携が臨床試験活動を強化し、北米は医薬品開発におけるセントラルラボサービスの重要な拠点となっています。

欧州は臨床試験用セントラルラボサービス市場を独占するもう一つの主要地域であり、定評のある製薬業界とドイツ、英国、フランスなどの国々で増加する臨床試験活動に支えられています。欧州医薬品庁（EMA）のような機関による強力な規制支援は、高い水準とコンプライアンスを保証し、多数の多国籍試験を誘致しています。希少疾患、腫瘍学、個別化医療が重視されるようになったことも、専門的な検査サービスに対する需要の高まりに寄与しています。さらに、欧州の共同研究環境と分子・ゲノム検査への投資の増加は、セントラルラボサービス市場における主要地域としての地位を強化しています。

臨床試験用セントラルラボサービス市場：競合情勢

臨床試験用セントラルラボサービス市場は、Labcorp、ICON plc、Eurofins Scientific、Thermo Fisher Scientific、Charles River Laboratoriesなどの既存企業が牽引しています。これらの企業は、包括的な臨床検査、データ管理、ロジスティクス・ソリューションを提供しており、国際的な臨床試験に不可欠です。先端技術、バイオマーカー検査、ゲノムサービスに対する重点的な投資は、競争上の優位性と規制遵守の維持に役立っています。新規参入企業は、デジタルデータ統合と遠隔検体管理における技術革新を重視し、競合を激化させています。継続的な研究開発と戦略的パートナーシップは、サービスの拡大を推進し、世界中の臨床試験の精度と効率を高め、医薬品開発のタイムラインを改善します。

目次

第1章 臨床試験用セントラルラボサービス市場の概要

  • 分析範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 臨床試験用セントラルラボサービスの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 臨床試験用セントラルラボサービス市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 臨床試験用セントラルラボサービス市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 臨床試験用セントラルラボサービスの市場情勢

  • 臨床試験用セントラルラボサービスの市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 臨床試験用セントラルラボサービス市場：サービス別

  • 概要
    • セグメント別シェア分析：サービス別
    • バイオマーカー検査サービス
    • 微生物学サービス
    • 解剖病理学/組織学
    • 薬物動態/薬力学（PK/PD）
    • ゲノム・分子検査
    • 検体採取・処理
    • ロジスティクス・検体管理
    • データ管理・レポート
    • その他

第8章 臨床試験用セントラルラボサービス市場：フェーズ別

  • 概要
    • セグメント別シェア分析：フェーズ別
    • フェーズI
    • フェーズII
    • フェーズIII
    • フェーズIV

第9章 臨床試験用セントラルラボサービス市場：適応症別

  • 概要
    • セグメント別シェア分析：適応症別
    • 腫瘍
    • 心臓病
    • 神経症
    • 感染症
    • 免疫・自己免疫疾患
    • その他

第10章 臨床試験用セントラルラボサービス市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 製薬・バイオテクノロジー企業
    • CRO（医薬品開発業務受託機関）
    • その他

第11章 臨床試験用セントラルラボサービス市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：臨床試験用セントラルラボサービス業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Labcorp
    • ICON plc
    • Eurofins Scientific
    • Thermo Fisher Scientific Inc.
    • Medpace
    • Q2 Solutions
    • Syneos Health
    • Charles River Laboratories
    • SGS
    • LabConnect
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV5322

REPORT HIGHLIGHT

Clinical Trial Central Laboratory Services Market size was valued at USD 4,123.12 Million in 2024, expanding at a CAGR of 9.6% from 2024 to 2032.

Clinical Trial Central Laboratory Services refer to specialized laboratories that provide standardized testing, sample analysis, and data management for clinical trials. These centralized labs ensure consistent, high-quality processing of biological samples such as blood, urine, or tissue from multiple trial sites. They play a crucial role in supporting drug development by delivering reliable, timely, and compliant laboratory results. Central labs facilitate protocol adherence, reduce variability, and enhance data integrity, helping sponsors and researchers make informed decisions during clinical studies. Their services often include biomarker testing, safety monitoring, and storage of specimens, all under strict regulatory guidelines.

Clinical Trial Central Laboratory Services Market- Market Dynamics

Increasing Demand for Efficient Clinical Trial Management

The growing complexity and scale of clinical trials are driving the demand for Clinical Trial Central Laboratory Services. Centralized labs offer standardized testing and consistent data quality across multiple trial sites, reducing variability and errors. This efficiency accelerates decision-making and regulatory approval processes. Additionally, the rise in global clinical trials, driven by pharmaceutical innovation and personalized medicine, necessitates reliable centralized testing facilities. Enhanced data management capabilities and integration with digital platforms further support trial accuracy and compliance. Overall, these factors contribute to the expanding adoption of central lab services, fueling market growth.

Clinical Trial Central Laboratory Services Market- Key Insights

According to our research analyst, the global Clinical Trial Central Laboratory Services Market is expected to develop at a CAGR of approximately 9.6% between 2024-2032.

Segmented by Service in 2023, the Biomarker Testing Services category dominated the market.

Based on Indication, the Oncology segment generated the most income in 2023.

Based onBased on region, in 2023, North America was the region with the highest revenue.

Clinical Trial Central Laboratory Services Market- Segmentation Analysis:

The global Clinical Trial Central Laboratory Services Market is divided into five categories: Service, Phase, End Use, Indication, and Region.

By service, the Clinical Trial Central Laboratory Services market is segmented into several key categories: Biomarker Testing Services, Microbiology Services, Anatomic Pathology/Histology, Pharmacokinetics/Pharmacodynamics (PK/PD), Genomic and Molecular Testing, Sample Collection and Processing, Logistics & Sample Management, Data Management & Reporting, and Others. Each service plays a vital role in supporting clinical trials through specialized testing, sample handling, and data analysis. Among these, Biomarker Testing Services dominate the market due to their critical importance in personalized medicine and targeted therapies. Biomarkers help in assessing disease progression, treatment efficacy, and safety, making them essential for drug development. The increasing focus on precision medicine and advancements in biomarker discovery drive high demand for these services, positioning Biomarker Testing as the leading segment in the clinical trial central laboratory landscape.

By indication, the Clinical Trial Central Laboratory Services market is segmented into Oncology, Cardiology, Neurology, Infectious Diseases, Immunology & Autoimmune Diseases, and Others. These segments represent the diverse therapeutic areas requiring specialized laboratory support during clinical trials. Among these, Oncology holds the dominant position in the market due to the high prevalence of cancer worldwide and the rapid development of targeted cancer therapies and immunotherapies. The complexity of oncology trials demands extensive biomarker testing, genomic analysis, and frequent monitoring, which drives significant reliance on central laboratory services. Moreover, increasing investment in oncology research and personalized medicine further fuels the growth of this segment, making it the leading indication area in the clinical trial central laboratory services market.

Clinical Trial Central Laboratory Services Market- Geographical Insights

Geographically, the Clinical Trial Central Laboratory Services Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Clinical Trial Central Laboratory Services market, driven by its advanced healthcare infrastructure, strong presence of pharmaceutical and biotechnology companies, and a high volume of clinical trials. The U.S., in particular, leads due to robust regulatory frameworks, substantial research funding, and the adoption of innovative technologies. The region's focus on precision medicine and growing demand for complex biomarker and genomic testing further fuel market growth. Additionally, collaborations between academic institutions and industry players enhance clinical trial activities, making North America a critical hub for central laboratory services in drug development.

Europe is another key region dominating the Clinical Trial Central Laboratory Services market, supported by a well-established pharmaceutical industry and increasing clinical trial activities across countries like Germany, the U.K., and France. Strong regulatory support from agencies such as the European Medicines Agency (EMA) ensures high standards and compliance, attracting numerous multinational trials. The rising emphasis on rare diseases, oncology, and personalized medicine also contributes to the growing demand for specialized laboratory services. Moreover, Europe's collaborative research environment and growing investments in molecular and genomic testing bolster its position as a leading region in the central laboratory services market.

Clinical Trial Central Laboratory Services Market- Competitive Landscape:

The Clinical Trial Central Laboratory Services market is led by established players such as Labcorp, ICON plc, Eurofins Scientific, Thermo Fisher Scientific, and Charles River Laboratories. These companies offer comprehensive laboratory testing, data management, and logistics solutions critical to global clinical trials. Heavy investments in advanced technologies, biomarker testing, and genomic services help maintain competitive advantages and regulatory compliance. New entrants emphasize innovation in digital data integration and remote sample management, intensifying competition. Continuous R&D and strategic partnerships drive service expansion, enhancing accuracy and efficiency in clinical trials worldwide and improving drug development timelines.

Recent Developments:

In March 2025, Labcorp announced the expansion of its central laboratory services with the launch of a new genomics testing facility in the U.K., enhancing its capabilities in biomarker discovery and precision medicine.

In January 2024, ICON plc acquired a data management company to strengthen its digital clinical trial platforms, improving real-time data access and analytics for faster study outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Labcorp
  • ICON plc
  • Eurofins Scientific
  • Thermo Fisher Scientific Inc.
  • Medpace
  • Q2 Solutions
  • Syneos Health
  • Charles River Laboratories
  • SGS
  • LabConnect
  • Others

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY SERVICE - MARKET ANALYSIS, 2019 - 2032

  • Biomarker Testing Services
  • Microbiology Services
  • Anatomic Pathology/Histology
  • Pharmacokinetics/Pharmacodynamics (PK/PD)
  • Genomic and Molecular Testing
  • Sample Collection and Processing
  • Logistics & Sample Management
  • Data Management & Reporting
  • Others

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY PHASE - MARKET ANALYSIS, 2019 - 2032

  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET BY INDICATION - MARKET ANALYSIS, 2019 - 2032
  • Oncology
  • Cardiology
  • Neurology
  • Infectious Diseases
  • Immunology & Autoimmune Diseases
  • Others

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Others

GLOBAL CLINICAL TRIAL CENTRAL LABORATORY SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Trial Central Laboratory Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Trial Central Laboratory Services Market Snippet by Service
    • 2.1.2. Clinical Trial Central Laboratory Services Market Snippet by Phase
    • 2.1.3. Clinical Trial Central Laboratory Services Market Snippet by Indication
    • 2.1.4. Clinical Trial Central Laboratory Services Market Snippet by End Use
    • 2.1.5. Clinical Trial Central Laboratory Services Market Snippet by Country
    • 2.1.6. Clinical Trial Central Laboratory Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Trial Central Laboratory Services Key Market Trends

  • 3.1. Clinical Trial Central Laboratory Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Trial Central Laboratory Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Trial Central Laboratory Services Market Opportunities
  • 3.4. Clinical Trial Central Laboratory Services Market Future Trends

4. Clinical Trial Central Laboratory Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Trial Central Laboratory Services Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Clinical Trial Central Laboratory Services Market Landscape

  • 6.1. Clinical Trial Central Laboratory Services Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Trial Central Laboratory Services Market - By Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service, 2023 & 2032 (%)
    • 7.1.2. Biomarker Testing Services
    • 7.1.3. Microbiology Services
    • 7.1.4. Anatomic Pathology/Histology
    • 7.1.5. Pharmacokinetics/Pharmacodynamics (PK/PD)
    • 7.1.6. Genomic and Molecular Testing
    • 7.1.7. Sample Collection and Processing
    • 7.1.8. Logistics & Sample Management
    • 7.1.9. Data Management & Reporting
    • 7.1.10. Others

8. Clinical Trial Central Laboratory Services Market - By Phase

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Phase, 2023 & 2032 (%)
    • 8.1.2. Phase I
    • 8.1.3. Phase II
    • 8.1.4. Phase III
    • 8.1.5. Phase IV

9. Clinical Trial Central Laboratory Services Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Cardiology
    • 9.1.4. Neurology
    • 9.1.5. Infectious Diseases
    • 9.1.6. Immunology & Autoimmune Diseases
    • 9.1.7. Others

10. Clinical Trial Central Laboratory Services Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical and Biotechnology Companies
    • 10.1.3. Contract Research Organizations
    • 10.1.4. Others

11. Clinical Trial Central Laboratory Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Clinical Trial Central Laboratory Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Clinical Trial Central Laboratory Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Clinical Trial Central Laboratory Services Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Clinical Trial Central Laboratory Services Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Clinical Trial Central Laboratory Services Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Phase, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Clinical Trial Central Laboratory Services Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Labcorp
    • 12.2.2. ICON plc
    • 12.2.3. Eurofins Scientific
    • 12.2.4. Thermo Fisher Scientific Inc.
    • 12.2.5. Medpace
    • 12.2.6. Q2 Solutions
    • 12.2.7. Syneos Health
    • 12.2.8. Charles River Laboratories
    • 12.2.9. SGS
    • 12.2.10. LabConnect
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us